Summary

The global microfluidics market demonstrates exceptional growth potential through 2035, driven by transformative applications across healthcare, pharmaceuticals, and industrial sectors. This sophisticated technology, which manipulates fluids at microscopic scales, continues to revolutionize traditional approaches to diagnostics, drug development, and process control. Medical applications currently dominate market share, with point-of-care diagnostics and pharmaceutical research leading growth, while industrial applications in environmental monitoring, food safety, and process control show substantial expansion potential.

Technological innovations in materials science, manufacturing processes, and digital integration continue to reduce production costs and enhance device functionality, enabling broader market adoption. The integration of artificial intelligence, automation, and advanced sensing capabilities creates new application possibilities and market opportunities. Key market drivers include increasing demand for rapid diagnostic solutions, growing investment in pharmaceutical research, and expanding applications in personalized medicine. As manufacturing processes improve and costs decrease, market adoption accelerates across both traditional and emerging applications in areas such as thermal management.

The Global Microfluidics Market 2025-2035 providing detailed insights into market dynamics, technological innovations, and growth opportunities from 2025 to 2035. Report contents include: The microfluidics market is experiencing transformative growth driven by breakthroughs in point-of-care diagnostics, drug discovery applications, and personalized medicine. Report contents include:

End-Market Segmentation

• Medical Market:
  • In-vitro diagnostics
  • Drug discovery and development
  • Genomics and proteomics
  • Point-of-care testing
  • Personalized medicine applications
  • Organ-on-chip platforms
• Industrial Market:
  • Environmental monitoring
  • Food and beverage testing
  • Oil and gas analysis
  • Electronic cooling solutions
  • Process control applications
  • Quality assurance systems
• Consumer Market:
  • Inkjet printing technologies
  • Consumer diagnostics
  • Wearable devices
  • Personal care applications
• Developments across materials, manufacturing processes, and integration technologies:
  • Advanced polymer technologies
  • PDMS alternatives
  • Glass and silicon innovations
  • Paper-based platforms
  • Hybrid materials development
  • 3D printing applications
  • Injection molding innovations
  • Hot embossing techniques
  • Wafer-level packaging
  • Integration technologies
• Emerging Technologies:
  • AI and machine learning integration
  • Biosensor developments
  • Digital microfluidics
  • Paper-based systems
  • Organ-on-chip platforms
• Applications and Market Opportunities
  • Diagnostics:
    • Infectious disease testing
    • Oncology applications
    • Cardiovascular diagnostics
    • Neurological testing
    • Genetic screening
  • Pharmaceutical Research:
    • Drug screening platforms
    • Genomics applications
    • Proteomics research
    • Cell analysis systems
    • High-throughput screening
  • Environmental and Industrial:
    • Water quality analysis
    • Food safety testing
    • Industrial process control
    • Environmental monitoring
    • Agricultural applications
• Market Drivers and Challenges
• Regulatory Landscape
• Detailed profiles of 200+ companies including 3M, 10X Genomics, Abbott, AbCellera, Accelix, Achira Labs, AGC, Agilent Technologies, AgPlus Diagnostics, Akonni Biosystems, ALiA Biotech, Aline inc, Allozymes, Alveo, Amberstone Biosciences Inc., Ande Corporation, Arrayit Corporation, Astraveus, Atomica, Atrandi Biosciences, AxBio, Baebies, Bartels Mikrotechnik, Becton Dickinson, BforCure, BGI, Bi.Flow Systems GmbH, Binx Health, Biocartis, Biomensio, bioMerieux, Bionano Genomics, Bioneer, Bio-Rad, BioSurfit, Biotechne, Boehringer Ingelheim, Bosch, Bruker Cellular Analysis, CapitalBiotech Corporation, Capsum, Cellbox Labs, Cellares, CellFE, Cellix Ltd., Charles River Laboratories, ClexBio, CN Bio, Cytovale, Danaher Corporation, Deepcell, Dermagnostix, DiaSorin Molecular, DNA electronics (DNAe), DNA Nudge, Dolomite Microfluidics, Eden Microfluidics, Element Biosciences, Elveflow, Emulate Bio, ENPLAS, Epicore Biosystems, Epigem, Evonetix, FEMTOprint, FinalSpark, Finnadvance, FLEXOMICS LLC, Fluigent, Fluxergy, Genalyte, GenSpeed Biotech GmbH, Hesperos Inc., Hicomp Microtech, Hochuen Medical, IDEX Health & Science, iLine Microsystems, Illumina, Imec, iMiGiNE, IMT AG, Inflammatix, Inorevia, Integra Biosciences, Invetech, InziGn Pte Ltd., Klearia, Kloe, Kypha, LightDeck, LioniX, LuminUltra Technologies, Lunaphore Technologies, Medimate, Mekonos, MeMed BV, Memo Therapeutics AG, Menarini Silicon Biosystems, Mesa labs, MGI Tech, MiCo BioMed USA, Microcaps AG, Microfluidic ChipShop, Micron Biomedical, Micronit, MicrofluidiX, Micropoint Technologies, microTEC, miDiagnostics, Miltenyi Biotec, Mimetas, Minos Biosciences, Mission Bio, Molbio Diagnostics, MZP tech, Nag Bioscience, NanoCellect, NanoDx, NanoEntek, Nanomix, NanoPass, NanoScribe, Netri, Nicoya, Nortis, Nuclera, Nutcracker Therapeutics, Okomera, Ondavia, Opgen Group, OPKO, Optolane Technologies, Orange Biomed, Osler Diagnostics, Oxford Nanopore Technologies, Pacific Biosciences, Paragraf, Parallel Fluidics, Pattern Bioscience, Perkinelmer, Philips Engineering Solutions, Phillips Medisize, PixCell Medical, Potomac Photonics (Goodfellow), Precision Nanosystems, Qiagen, Qorvo Biotechnologies, Quanterix, QuantuMDx, Quantum-Si, QuidelOrtho, Qurin Diagnostics, Rab-Microfluidics and more....
• Future Outlook Analysis of emerging opportunities
• Supply Chain Analysis:
  • Raw materials suppliers
  • Component manufacturers
  • Device integrators
  • End-user markets
  • Distribution channels
• Market Opportunities

ページTOPに戻る

Table of Contents

1 EXECUTIVE SUMMARY 20

1.1 Market Size 20
1.2 Emerging Trends and Technologies 21
1.3 Market Drivers 23
1.3.1 Advancements in Point-of-Care Diagnostics 24
1.3.1.1 Rapid Testing for Infectious Diseases 24
1.3.1.2 Chronic Disease Management 25
1.3.1.3 Decentralized Healthcare Trends 25
1.3.2 Increasing Demand for Personalized Medicine 26
1.3.2.1 Genomics and Proteomics Applications 26
1.3.2.2 Targeted Drug Delivery Systems 27
1.3.2.3 Companion Diagnostics 27
1.3.3 Growth in Drug Discovery and Life Sciences Research 27
1.3.3.1 High-Throughput Screening 28
1.3.3.2 Organ-on-a-Chip Models 28
1.3.3.3 Single-Cell Analysis 30
1.3.4 Emerging Applications in Industrial and Environmental Monitoring 30
1.3.4.1 Water Quality Testing 30
1.3.4.2 Food Safety Analysis 31
1.3.4.3 Industrial Process Control 31
1.4 Market Restraints 32
1.4.1 High Initial Costs and Complexities in Manufacturing 32
1.4.2 Standardization and Regulatory Challenges 32
1.4.3 Limited Awareness and Adoption in Emerging Markets 33
1.4.4 Scaling Up Production While Maintaining Quality 33
1.4.5 Competing Technologies and Alternative Solutions 33
1.5 Market Opportunities 34
1.5.1 Integration of AI and IoT in Microfluidic Devices 34
1.5.2 Lab-to-fab 35
1.5.3 Novel Applications in Organ-on-a-Chip and 3D Cell Culture 35
1.5.4 Space Research Applications 35
1.5.5 Synthetic Biology 35
1.5.6 Advanced Materials Development 36
1.5.7 Food Safety and Quality 36
1.6 Competitive Landscape Overview 37

2 INTRODUCTION 39

2.1 Types of Microfluidic Technologies 39
2.1.1 Continuous-flow Microfluidics 39
2.1.2 Droplet-based Microfluidics 40
2.1.3 Digital Microfluidics 40
2.1.4 Paper-based Microfluidics 41

3 GLOBAL MARKET SIZE AND FORECAST (2025-2035) 44

3.1 Overall Market Size and Growth Rate 44
3.1.1 Historical Market Size (2020-2024) 44
3.1.2 Forecast Market Size (2025-2035) 45
3.2 Market Segmentation by End-Use Markets 45
3.2.1 Consumer Market 46
3.2.1.1 Inkjet Printing 46
3.2.1.2 Consumer Diagnostics 47
3.2.1.3 Wearable Devices 47
3.2.2 Industrial Market 48
3.2.2.1 Environmental Monitoring 49
3.2.2.2 Food and Beverage Testing 49
3.2.2.3 Oil and Gas Analysis 50
3.2.2.4 Electronic Cooling Solutions 50
3.2.3 Medical Market 50
3.2.3.1 In-Vitro Diagnostics 51
3.2.3.2 Drug Discovery and Development 51
3.2.3.3 Genomics and Proteomics 52
3.2.3.4 Point-of-Care Testing 52
3.3 Regional Market Analysis 52
3.3.1 North America 53
3.3.2 Europe 53
3.3.3 Asia-Pacific 53
3.3.4 Rest of the World 53

4 MARKETS AND APPLICATIONS 54

4.1 Diagnostics 55
4.1.1 Overview 55
4.1.2 Emerging Trends 55
4.1.2.1 Artificial Intelligence Integration 55
4.1.2.2 Smartphone-Based Systems 56
4.1.2.3 Paper-Based Microfluidics 56
4.1.2.4 Digital Microfluidics 56
4.1.2.5 3D-Printed Microfluidics 57
4.1.3 Infectious Diseases 58
4.1.3.1 Viral Infection Detection 58
4.1.3.2 Bacterial Infection Management 59
4.1.3.3 Emerging Pathogen Response 59
4.1.4 Oncology 59
4.1.4.1 Circulating Tumor Cell Analysis 59
4.1.4.2 Molecular Profiling and Monitoring 60
4.1.4.3 Treatment Response Monitoring 60
4.1.5 Cardiology 60
4.1.5.1 Acute Cardiac Event Management 60
4.1.5.2 Chronic Disease Monitoring 61
4.1.6 Others 61
4.1.6.1 Neurological Disorders 61
4.1.6.1.1 Blood-Brain Barrier Modeling 61
4.1.6.1.2 Neurodegenerative Disease Diagnostics 61
4.1.6.2 Endocrine Disorders 62
4.1.6.2.1 Diabetes Management 62
4.1.6.2.2 Thyroid Function Testing 62
4.1.6.3 Autoimmune Disease Diagnostics 62
4.1.6.3.1 Comprehensive Antibody Profiling 62
4.1.6.3.2 Inflammatory Response Analysis 63
4.1.6.4 Genetic Testing Applications 63
4.1.6.4.1 Prenatal Testing 63
4.1.6.4.2 Hereditary Disease Screening 63
4.1.6.5 Rare Disease Diagnostics 63
4.2 Pharmaceutical and Life Science Research 64
4.2.1 Drug Screening 65
4.2.2 Genomics 65
4.2.3 Proteomics 66
4.2.4 Cell Analysis 66
4.3 Inkjet Printing 67
4.3.1 Consumer Printing 67
4.3.2 Industrial Printing 68
4.3.3 3D Printing 68
4.4 Environmental and Food Safety Testing 68
4.4.1 Water Quality Analysis 69
4.4.2 Food Contaminant Detection 70
4.4.3 Soil Analysis 71
4.5 Others (e.g., Cosmetics, Agriculture) 72
4.5.1 Cosmetics and Personal Care Manufacturing 72
4.5.2 Automotive Fluids Analysis 72
4.5.3 Energy Production Monitoring 73
4.5.4 Materials Manufacturing 74
4.5.5 Chemical Processing 74
4.5.6 Agriculture 75
4.6 Module Types 75
4.6.1 Microfluidic Chips 77
4.6.2 Pumps and Valves 78
4.6.3 Sensors and Detectors 80
4.6.4 Microfluidic Cartridges 80
4.6.5 Others 81
4.7 Materials 82
4.7.1 Polymer 82
4.7.1.1 Thermoplastics (PMMA, COC, PS) 82
4.7.1.2 Thermosets 83
4.7.1.3 PDMS (Polydimethylsiloxane) 84
4.7.2 Glass Wafers 84
4.7.3 Silicon Wafers 85
4.7.4 Paper and Other Materials 85
4.7.4.1 Multiplexed Analysis Platforms 86
4.7.4.2 Integration with IoT for Real-time Monitoring 86

5 MARKET TRENDS 87

5.1 Consumer Market Trends 87
5.1.1 Evolution of Inkjet Printing Technologies 87
5.1.1.1 Continuous Inkjet (CIJ) vs. Drop-on-Demand (DOD) 87
5.1.1.2 Advancements in Printhead Technology 87
5.1.1.3 Eco-friendly Inks and Sustainability Trends 88
5.1.2 Emerging Consumer Diagnostics and Wellness Devices 88
5.1.2.1 At-home Testing Kits 89
5.1.2.2 Wearable Microfluidic Devices 89
5.1.2.3 Personalized Nutrition and Hydration Monitoring 90
5.2 Industrial Market Trends 91
5.2.1 Advancements in Environmental and Food Safety Testing 91
5.2.1.1 Rapid On-site Detection Systems 91
5.2.1.2 Multiplexed Analysis Platforms 92
5.2.1.3 Integration with IoT for Real-time Monitoring 92
5.2.2 Applications in Oil Testing and Agriculture 93
5.2.2.1 In-situ Oil Analysis 93
5.2.2.2 Precision Agriculture and Crop Management 93
5.2.2.3 Soil Health Monitoring 94
5.2.3 Electronic Cooling Solutions 94
5.2.3.1 Microfluidic Cooling for High-Performance Computing 95
5.2.3.2 Innovations in Data Center Cooling 95
5.2.3.2.1 Thermal management 95
5.2.3.3 Challenges and Opportunities in Chip-level Cooling 96
5.3 Medical Market Trends 97
5.3.1 Point-of-Care Diagnostics Evolution 97
5.3.1.1 Smartphone-integrated Diagnostics 97
5.3.1.2 Multiplexed POC Platforms 98
5.3.1.3 Emerging Biomarkers and Test Types 98
5.3.2 Microfluidics in Drug Discovery and Development 99
5.3.2.1 High-Throughput Screening Platforms 100
5.3.2.2 Organ-on-a-Chip for Drug Testing 100
5.3.2.3 Personalized Drug Efficacy Testing 100
5.3.3 Next-Generation Sequencing Advancements 101
5.3.3.1 Microfluidic-based Library Preparation 101
5.3.3.2 Single-cell Sequencing Platforms 102
5.3.3.3 Long-read Sequencing Technologies 103
5.3.4 Microphysiological Systems and Organ-on-a-Chip 104
5.3.4.1 Multi-organ Systems 104
5.3.4.2 Disease Modelling 104
5.3.4.3 Personalized Medicine Applications 104
5.3.5 Cell Analysis and Therapy Applications 105
5.3.5.1 Circulating Tumor Cell (CTC) Analysis 106
5.3.5.2 CAR-T Cell Manufacturing 106
5.3.5.3 Stem Cell Research and Therapy 107

6 SUPPLY CHAIN ANALYSIS 108

6.1 Raw Materials and Components Suppliers 108
6.2 Microfluidic Chip Manufacturers 109
6.3 Module and Device Integrators 109
6.4 End-Users 110

7 TECHNOLOGY TRENDS AND INNOVATIONS 112

7.1 Development of Biosensors 112
7.1.1 Photonic Sensors for Cell Therapy 112
7.1.1.1 Applications in Cell Sorting and Analysis 112
7.1.1.2 Challenges and Future Prospects 113
7.1.2 Silicon-Based Biosensors for Point-of-Care Diagnostics 113
7.1.2.1 CMOS-Integrated Biosensors 114
7.1.2.2 Label-free Detection Methods 114
7.1.2.3 Multiplexed Sensing Platforms 115
7.2 Materials Innovations 116
7.2.1 Advancements in Polymer Technologies 116
7.2.1.1 High-Performance Thermoplastics 116
7.2.1.2 Biodegradable Polymers 117
7.2.1.3 Surface Modification Techniques 118
7.2.2 PDMS Alternatives and Hybrid Materials 119
7.2.2.1 Thermoplastic Elastomers 119
7.2.2.2 Fluoropolymers 119
7.2.2.3 Glass-Polymer Hybrids 119
7.2.3 Glass and Silicon Wafer Innovations 120
7.2.3.1 Ultra-thin Glass Substrates 120
7.2.3.2 3D-Structured Silicon 120
7.2.3.3 Nanoporous Materials 121
7.3 Manufacturing Trends 121
7.3.1 Polymer Manufacturing Advancements 121
7.3.1.1 Injection Molding Innovations 122
7.3.1.2 Hot Embossing Techniques 122
7.3.1.3 3D Printing of Microfluidic Devices 122
7.3.2 Silicon and Glass Manufacturing Techniques 123
7.3.2.1 Deep Reactive Ion Etching (DRIE) 123
7.3.2.2 Wafer-level Packaging 123
7.3.2.3 Through-Silicon Vias (TSVs) 124
7.3.3 Backend Processes and Integration 125
7.3.3.1 Bonding Technologies 125
7.3.4 Surface Treatments and Coatings 126
7.3.4.1 Integration of Electronics and Microfluidics 127
7.4 Emerging Technologies 128
7.4.1 AI and Machine Learning Integration 128
7.4.1.1 Automated Design of Microfluidic Circuits 129
7.4.1.2 Predictive Maintenance of Microfluidic Systems 129
7.4.1.3 Data Analysis and Interpretation 130
7.4.2 3D Printing in Microfluidics 131
7.4.2.1 Stereolithography (SLA) for Microfluidics 131
7.4.2.2 Multi-material 3D Printing 131
7.4.2.3 Bioprinting of Tissue Constructs 131
7.4.3 Paper-Based Microfluidics 132
7.4.3.1 Fabrication Methods 132
7.4.3.2 Applications in Low-Resource Settings 133
7.4.3.3 Integration with Smartphones for Readout 133

8 REGULATORY LANDSCAPE 135

8.1 Overview of Regulatory Framework for Microfluidic Devices 135
8.2 FDA Regulations (USA) 135
8.2.1 Classification of Microfluidic Devices 135
8.2.2 Premarket Approval (PMA) Process 136
8.2.3 510(k) Clearance Process 136
8.3 CE Marking (Europe) 137
8.3.1 Medical Device Regulation (MDR) 137
8.3.2 In Vitro Diagnostic Regulation (IVDR) 138
8.3.3 Conformity Assessment Procedures 138
8.4 NMPA Regulations (China) 139
8.4.1 Registration Process for Medical Devices 139
8.4.2 Clinical Trial Requirements 140
8.4.3 Manufacturing and Quality Control Standards 140

9 FUTURE OUTLOOK AND MARKET OPPORTUNITIES 142

9.1 Emerging Applications and Use Cases 142
9.1.1 Microfluidics in Space Research 142
9.1.2 Microbiome Analysis and Engineering 142
9.2 Neurotechnology 143
9.2.1 Neurotechnology and Brain-on-a-Chip 143
9.2.2 Synthetic Biology and Biofabrication 143
9.2.3 Advanced Materials Testing and Development 144
9.3 Potential Impact of Generative AI on Microfluidics 145
9.3.1 AI-Driven Design Optimization 145
9.3.2 Predictive Modeling of Fluid Dynamics 145
9.3.3 Automated Data Analysis and Interpretation 145
9.4 Microfluidics in Precision Medicine and Personalized Healthcare 146
9.4.1 Liquid Biopsy and Circulating Biomarkers 146
9.4.2 Personalized Drug Screening 146
9.4.3 Microfluidic Devices for Continuous Health Monitoring 146
9.5 Opportunities in Developing Economies 147
9.5.1 Point-of-Care Diagnostics for Resource-Limited Settings 147
9.5.2 Affordable Microfluidic Solutions for Agriculture 148
9.5.3 Environmental Monitoring in Rapidly Industrializing Regions 148

10 COMPANY PROFILES 150 (200 company profiles)

11 APPENDICES 289

11.1 Glossary of Terms 289
11.2 List of Abbreviations 290
11.3 Research Methodology 291

12 REFERENCES 293

ページTOPに戻る

List of Tables/Graphs

List of Tables

Table 1. Global Microfluidics Market Size and Growth Rate, 2025-2035. 21
Table 2. Emerging Trends and Technologies. 22
Table 3. Key Market Drivers and Challenges in Microfludics. 23
Table 4. Point-of-Care Diagnostics Market Growth, 2025-2035. 24
Table 5. Rapid Test Antigen Testing Kit. 24
Table 6. Decentralized Healthcare Trends. 25
Table 7. Genomics and Proteomics Applications. 26
Table 8. Organ-on-a-Chip Models. 29
Table 9. Emerging Opportunities in Microfluidics Market. 30
Table 10. Market Restraints. 32
Table 11. Competing Technologies and Alternative Solutions. 33
Table 12. Types of Microfluidic Technologies and Their Applications. 39
Table 13. Comparison of Microfluidics with Alternative Technologies. 42
Table 14. Global Microfluidics Market Size by End-Market, 2020-2024 ($B). 44
Table 15. Global Microfluidics Market Size by End-Market, 2025-2035 ($B). 45
Table 16. Market Share by End-Market Segment, 2025-2035 (%). 45
Table 17. Consumer Market Size by Application, 2025-2035 ($B). 46
Table 18. Industrial Market Size by Application, 2025-2035 ($B). 48
Table 19. Medical Market Size by Application, 2025-2035 ($B). 50
Table 20. Regional Market Size, 2025-2035 ($B). 52
Table 21. Microfluidics Markets and Applications. 54
Table 22. Current Implementation Areas. 55
Table 23. Diagnostics Market by Disease Area, 2025-2035 ($B). 57
Table 24. Pharmaceutical and Life Science Research Market Trends. 64
Table 25. Comparison of Microfluidics Platforms with conventional methods. 65
Table 26. Microfluidics application in genomics. 66
Table 27. Microfluidic proteomics application. 66
Table 28. Types of cell analysis. 67
Table 29. Inkjet Printing Market by Type, 2025-2035 ($B). 67
Table 30. Comparison of inkjet printing techniques. 68
Table 31. Environmental and Food Safety Testing Market, 2025-2035 ($B). 69
Table 32. Comparison of microfluidics with traditional environmental and food safety testing methods. 69
Table 33. Comparion of microfluidics with traditional methods in water quality analysis. 69
Table 34. Comparison of microfluidics for food contaminant detection. 70
Table 35. Comparison of microfluidics for soil analysis to other conventional methods. 71
Table 36. Microfluidics for energy production monitoring compared to other conventional methods. 73
Table 37. Microfluidics for monitoring chemical manufacturing processes compared to other methods. 74
Table 38. Market Size by Module Type, 2025-2035 ($B). 75
Table 39. Common materials in microfluidic chips. 77
Table 40. Pump Technologies in Microfluidics. 78
Table 41. Valve Technologies in Microfluidics. 79
Table 42. Sensors and detectors in microfluidic systems, . 80
Table 43. Market Share by Material Type, 2025 vs 2035. 82
Table 44. Properties of Thermoplastics in Microfluidics. 82
Table 45. Types of Thermosets in Microfluidics. 83
Table 46. Properties of glass wafers. 84
Table 47. Paper materials utilized in microfluidics. 85
Table 48. Continuous Inkjet (CIJ) vs. Drop-on-Demand (DOD). 87
Table 49. Advancements in Printhead Technology. 87
Table 50. Sustainability metrics for Eco-friendly inks. 88
Table 51. Types of Wearable Microfluidic Devices. 90
Table 52. Rapid On-site Detection Systems. 91
Table 53. Multiplexed Analysis Platforms 92
Table 54. IoT Integration for Real-time Monitoring. 93
Table 55. Precision Agriculture Applications. 93
Table 56. Microfluidic Cooling Applications in Electronics. 94
Table 57. Challenges and Opportunities in Chip-level Cooling. 96
Table 58. Multiplexed POC Platform Types. 98
Table 59. Emerging Biomarkers and Test Types. 99
Table 60. Comparison of Microfluidic Platforms for Drug Discovery. 99
Table 61. Next-Generation Sequencing Advancements. 101
Table 62. Single-cell Sequencing Platforms. 102
Table 63. Long-read Sequencing Technologies. 103
Table 64. Personalized Medicine Applications in Microphysiological Systems. 105
Table 65. Cell Analysis and Therapy Applications in Microfluidics. 106
Table 66. Raw Materials and Components Suppliers. 108
Table 67. Microfluidic Chip Manufacturers. 109
Table 68. Module and Device Integrators. 109
Table 69. Microfluidics End User Categories and Applications. 110
Table 70. Comparison of Photonic Sensors for Cell Therapy Applications. 112
Table 71. Applications in Cell Sorting and Analysis. 113
Table 72. CMOS-Integrated Biosensors. 114
Table 73. Label-free Detection Methods. 114
Table 74. Multiplexed Sensing Platforms. 115
Table 75. Advanced Polymer Materials for Microfluidics, Properties and Applications. 116
Table 76. High-Performance Thermoplastics. 116
Table 77. Biodegradable Polymers. 117
Table 78. Surface Modification Techniques. 118
Table 79. Polymer Manufacturing Techniques Comparison. 121
Table 80. Hot Embossing Techniques. 122
Table 81. Silicon and Glass Manufacturing Techniques, Pros and Cons. 123
Table 82. Backend Processes and Integration Trends. 125
Table 83. Bonding Technologies. 125
Table 84. AI and ML Applications in Microfluidics,. 128
Table 85. Multi-material 3D Printing for Microfluidics. 131
Table 86.Bioprinting in Microfluidics 132
Table 87. Paper-Based Microfluidics Fabrication Methods. 133
Table 88. Applications in Low-Resource Settings. 133
Table 89. Global Regulatory Framework for Microfluidic Devices. 135
Table 90. FDA Classification of Microfluidic Devices. 135
Table 91. Microfluidics Applications in Space Research. 142
Table 92. Microbiome Applications. 142
Table 93. Synthetic Biology and Biofabrication Applications. 144
Table 94. Microfluidic Applications in Materials Testing and Development 144
Table 95. Glossary of terms. 289
Table 96. List of Abbreviations. 290

List of Figures

Figure 1. Microfluidic chip. 20
Figure 2. Global Microfluidics Market Size and Growth Rate, 2025-2035. 21
Figure 3. Body on Chip. 29
Figure 4. Applications of microfluidics in food safety monitoring. 36
Figure 5. Microfluidics Market Map. 38
Figure 6. A digital microfluidic system with 3D microstructures for single-cell culture. 41
Figure 7. Characterization of paper microfluidics. 42
Figure 8. Global Microfluidics Market Size by End-Market, 2020-2024 ($B). 44
Figure 9. Global Microfluidics Market Size by End-Market, 2025-2035 ($B). 45
Figure 10. Consumer Market Size by Application, 2025-2035 ($B).. 46
Figure 11. Wearable sweat sensor. 48
Figure 12. Industrial Market Size by Application, 2025-2035 ($B). 49
Figure 13. Medical Market Size by Application, 2025-2035 ($B). 51
Figure 14. Regional Market Size, 2025-2035 ($B). 53
Figure 15. Diagnostics Market by Disease Area, 2025-2035 ($B). 58
Figure 16. Market Size by Module Type, 2025-2035 ($B). 76
Figure 17. Overview of the Microfluidics Supply Chain. 108
Figure 18. Illumina Patterned Flow Cell Technology. 121
Figure 19. CELLINK BIO X Bioprinter. 132
Figure 20. 10x Genomics Chromium Controller. 151
Figure 21. Abbott i-STAT System. 151
Figure 22. Agilent 2100 Bioanalyzer. 155
Figure 23. Agilis Reader. 156
Figure 24. TruArray technology. 157
Figure 25. be.well™ Analyzer. 159
Figure 26. Lakhesys - The Benchtop Cell Factory. 162
Figure 27. STYX platform. 163
Figure 28. BAEBIES FINDER. 165
Figure 29. Bartels Mikrotechnik Micropumps. 166
Figure 30. Chronos platform. 167
Figure 31. Idylla™ platform. 169
Figure 32. Biomensio Smart multianalyte handheld detection. 170
Figure 33. Experion™ Automated Electrophoresis Station. 172
Figure 34. spinit® platform. 173
Figure 35. Infinity MTx platform. 179
Figure 36. IntelliSep. 182
Figure 37. DNA Nudge analytic device. 185
Figure 38. AVITI™ System. 187
Figure 39. Emulate Organ-Chip Instruments. 189
Figure 40. EPIGEM lab on a chip. 191
Figure 41. Bioprocessor with eight electrodes attached to four arrays each housing a cluster of brain cells. 193
Figure 42. Fluxergy Analyzer. 196
Figure 43. MiSeq System. 201
Figure 44. TriVerity™ Acute Infection and Sepsis Test. 203
Figure 45. Klearia's the PANDa (Portable ANalyzer for trace metals Detection). 206
Figure 46. TriPleX™ . 209
Figure 47. Fisic Medimate self-test platform. 210
Figure 48. DEPArray™ platform. 213
Figure 49. MACSQuant® Tyto® system. 219
Figure 50. OrganoPlate®. 220
Figure 51. OhmX Analyzer. 222
Figure 52. NanoDx Tbit System. 225
Figure 53. Claros 1 analyzer. 232
Figure 54. Genotizer™ . 233
Figure 55. OBM rapid A1c meter. 234
Figure 56. Osler HemaTap® system. 235
Figure 57. MinION portable nanopore sequencing device. 236
Figure 58. GridION. 236
Figure 59. Graphene Field Effect Transistor. 238
Figure 60. PixCell HemScreen. 241
Figure 61. QuantumX MX879B. 245
Figure 62. Quidel Triage ® System. 246
Figure 63. Qurin Biosensor. 247
Figure 64. Oleum Oracle®. 249
Figure 65. Apollo. 250
Figure 66. The LabChip GXII Touch Protein Characterization System . 251
Figure 67. GenMark's ePlex system . 253
Figure 68. rqmicro COUNT . 254
Figure 69. VerePLEX™ Biosystem. 259
Figure 70. Atellica® VTLi Patient-side Immunoassay Analyzer. 261
Figure 71. Nio™ dPCR. 266
Figure 72. Takara Bio's ICELL8 technology . 272
Figure 73. Talis One Test System. 273
Figure 74. VisionSort - ThinkCyte. 276